Nivalis Therapeutics stockholders approve merger and reorganization plan
Nivalis Therapeutics announced that stockholders approved all of the merger-related proposals with and Alpine Immune Sciences. Nivalis' name will change to “Alpine Immune Sciences, Inc.” The closing of the merger is expected to occur on July 24, 2017. July 20, 2017